Cargando…
Poor glycaemic control and ectopic fat deposition mediates the increased risk of non-alcoholic steatohepatitis in high-risk populations with type 2 diabetes: Insights from Bayesian-network modelling
BACKGROUND: An estimated 55.5% and 37.3% of people globally with type 2 diabetes (T2D) will have concomitant non-alcoholic fatty liver disease (NAFLD) and the more severe fibroinflammatory stage, non-alcoholic steatohepatitis (NASH). NAFLD and NASH prevalence is projected to increase exponentially o...
Autores principales: | Waddell, T., Namburete, A., Duckworth, P., Fichera, A., Telford, A., Thomaides-Brears, H., Cuthbertson, D. J., Brady, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992174/ https://www.ncbi.nlm.nih.gov/pubmed/36909341 http://dx.doi.org/10.3389/fendo.2023.1063882 |
Ejemplares similares
-
Bayesian networks and imaging-derived phenotypes highlight the role of fat deposition in COVID-19 hospitalisation risk
por: Waddell, T., et al.
Publicado: (2023) -
Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes
por: Waddell, Tom, et al.
Publicado: (2022) -
Ectopic fat deposition in the liver and pancreas and the presence of excess visceral adipose tissue significantly increase hospitalisation risk following COVID-19
por: Waddell, Tom, et al.
Publicado: (2022) -
Mo1620: ECTOPIC FAT DEPOSITION IN THE LIVER AND PANCREAS AND THE PRESENCE OF EXCESS VISCERAL ADIPOSE TISSUE SIGNIFICANTLY INCREASE HOSPITALISATION RISK FOLLOWING COVID-19.
por: Waddell, Tom H., et al.
Publicado: (2022) -
Editorial: Cardiovascular imaging in the integrated assessment of metabolic health
por: Thomaides-Brears, Helena B., et al.
Publicado: (2023)